| 1 |
LANKALA C R， YASIR M， ISHAK A， et al. Application of Nanotechnology for Diagnosis and Drug Delivery in Atherosclerosis： A New Horizon of Treatment［J］. Curr Probl Cardiol， 2023： 101671.
|
| 2 |
王单单. MR与多层螺旋CT对诊断颈动脉狭窄和粥样硬化斑块的临床应用价值分析［J］. 中外医学研究，2022，20（26）：78-81.
|
| 3 |
SINGH S B， NG S J， LAU H C， et al. Emerging PET tracers in cardiac molecular imaging［J］. Cardiol Ther， 2023， 12（1）： 85-99.
|
| 4 |
STOJKOVIC S， KAMPF S， HARKOT O， et al. Soluble ST2 in Patients with Carotid Artery Stenosis-Association with Plaque Morphology and Long-Term Outcome［J］. Int J Mol Sci， 2023， 24（10）： 9007.
|
| 5 |
LI Q， CAI M， WANG H， et al. Diagnostic Performance of Contrast‐Enhanced Ultrasound and High‐Resolution Magnetic Resonance Imaging for Carotid Atherosclerotic Plaques： A Systematic Review and Meta‐Analysis［J］. J Ultrasound Med， 2022，42（3）：739-749.
|
| 6 |
SONGCA S P. Combinations of Photodynamic Therapy with Other Minimally Invasive Therapeutic Technologies against Cancer and Microbial Infections［J］. Int J Mol Sci， 2023， 24（13）： 10875.
|
| 7 |
ZHANG X， CENTURION F， MISRA A， et al. Molecularly targeted nanomedicine enabled by inorganic nanoparticles for atherosclerosis diagnosis and treatment［J］. Adv Drug Deliv Rev， 2023，194：114709.
|
| 8 |
WU Q， PAN W， WU G， et al. CD40-targeting magnetic nanoparticles for MRI/optical dual-modality molecular imaging of vulnerable atherosclerotic plaques［J］. Atherosclerosis， 2023， 369： 17-26.
|
| 9 |
WANG Y， FENG Y， YANG X， et al. Diagnosis of Atherosclerotic Plaques Using Vascular Endothelial Growth Factor Receptor-2 Targeting Antibody Nano-microbubble as Ultrasound Contrast Agent ［J］. Comput Math Methods Med， 2022， 2022：6524592.
|
| 10 |
LI P， JIN L， FENG L， et al. ICAM-1-carrying targeted nano contrast agent for evaluating inflammatory injury in rabbits with atherosclerosis ［J］. Sci Rep， 2021， 11（1）： 1-10.
|
| 11 |
FEIL S， STOWBUR D， SCHORG B F， et al. Noninvasive Detection of Smooth Muscle Cell-Derived Hot Spots to Study Atherosclerosis by PET/MRI in Mice［J］. Circul Res， 2023， 132（6）： 747-750.
|
| 12 |
IMRAN M， JHA L A， HASAN N， et al. “Nanodecoys”-Future of drug delivery by encapsulating nanoparticles in natural cell membranes ［J］. Int J Pharm， 2022： 121790.
|
| 13 |
BONNET S， PRéVOT G， MORNET S， et al. A nano-emulsion platform functionalized with a fully human scfv-fc antibody for atheroma targeting： Towards a theranostic approach to atherosclerosis ［J］. Int J Mol Sci， 2021， 22（10）： 5188.
|
| 14 |
ZHANG Y， YIN Y， ZHANG W， et al. Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis ［J］. J Nanobiotechnology， 2021， 19（1）： 1-13.
|
| 15 |
CHEN W， SCHILPEROORT M， CAO Y， et al. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis ［J］. Nat Rev Cardiol， 2022， 19（4）： 228-249.
|
| 16 |
WU M， LI X， GUO Q， et al. Magnetic mesoporous silica nanoparticles-aided dual MR/NIRF imaging to identify macrophage enrichment in atherosclerotic plaques ［J］. Nanomedicine， 2021， 32： 102330.
|
| 17 |
JIANG Z， GENG X， SU L， et al. Neutrophil membrane camouflaged nanoprobes for NIR-II fluorescence imaging of inflamed， high-risk atherosclerotic plaques in mouse and rabbit models ［J］. Mat Today Chem， 2022， 26： 101062.
|
| 18 |
WANG Q， LOU R， YIN Q， et al. A nano-detection system based on a chemical probe for early diagnosis of atherosclerosis in situ ［J］. Analyst， 2021， 146（14）： 4674-4682.
|
| 19 |
LIN L， WANG L V. The emerging role of photoacoustic imaging in clinical oncology［J］. Nat Rev Clin Oncol， 2022， 19（6）： 365-384.
|
| 20 |
JIANG Y W， TANG W J， GAO G， et al. Lipid droplet-hitchhiking probe creates Trojan foam cells for fluorescence/photoacoustic imaging of atherosclerotic plaques［J］. Biosensors Bioelectron， 2022， 216： 114613.
|
| 21 |
DENG H， KONOPKA C J， PRABHU S， et al. Dextran-Mimetic Quantum Dots for Multimodal Macrophage Imaging In Vivo， Ex Vivo， and In Situ［J］. ACS Nano， 2022， 16（2）： 1999-2012.
|
| 22 |
WU K， YAO C， YANG D， et al. A functional DNA nanosensor for highly sensitive and selective imaging of ClO- in atherosclerotic plaques ［J］. Biosensors Bioelectron， 2022， 209： 114273.
|
| 23 |
OUYANG J， XIE A， ZHOU J， et al. Minimally invasive nanomedicine： nanotechnology in photo-/ultrasound-/radiation-/magnetism-mediated therapy and imaging［J］. Chem Soc Rev， 2022， 51（12）：4996-5041.
|
| 24 |
SULTAN D， LI W， DETERING L， et al. Assessment of ultrasmall nanocluster for early and accurate detection of atherosclerosis using positron emission tomography/computed tomography ［J］. Nanomedicine， 2021， 36： 102416.
|
| 25 |
LIU M， ZHANG Y， MA X， et al. Synthesis and Characterization of Fucoidan-Chitosan Nanoparticles Targeting P-Selectin for Effective Atherosclerosis Therapy［J］. Oxid Med Cell Longev， 2022， 2022： 8006642.
|
| 26 |
LI G， XU F， YANG B， et al. A nanotherapy responsive to the inflammatory microenvironment for the dual-targeted treatment of atherosclerosis［J］. Nanomedicine， 2022， 43： 102557.
|
| 27 |
HUANG X， LIU C， KONG N， et al. Synthesis of siRNA nanoparticles to silence plaque-destabilizing gene in atherosclerotic lesional macrophages［J］. Nat Protoc， 2022， 17（3）： 748-780.
|
| 28 |
CHIN D D， POON C， WANG J， et al. miR-145 micelles mitigate atherosclerosis by modulating vascular smooth muscle cell phenotype ［J］. Biomaterials， 2021， 273： 120810.
|
| 29 |
GUO L， MIAO Y， WANG Y， et al. Biomimetic Macrophage Membrane and Lipidated Peptide Hybrid Nanovesicles for Atherosclerosis Therapy ［J］. Adv Func Mat， 2022： 2204822.
|
| 30 |
MA X， ZHANG T， LUO Z， et al. Functional nano-vector boost anti-atherosclerosis efficacy of berberine in Apoe （-/-） mice ［J］. Acta Pharm Sin B， 2020， 10（9）： 1769-1783.
|
| 31 |
WANG S， ZHOU Y， LIANG X， et al. Platinum-cerium bimetallic nano-raspberry for atherosclerosis treatment via synergistic foam cell inhibition and P2Y12 targeted antiplatelet aggregation ［J］. Chem Engin J， 2022， 430： 132859.
|
| 32 |
SUN W， XU Y， YAO Y， et al. Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy ［J］. J Nanobiotechnol， 2022， 20（1）： 1-17.
|
| 33 |
WU Z， WU R， LI X， et al. Multi‐pathway microenvironment regulation for atherosclerosis therapy based on beta‐cyclodextrin/l‐arginine/Au nanomotors with dual‐mode propulsion［J］. Small， 2022， 18（9）： 2104120.
|
| 34 |
ZHOU J， NIU C， BIVING H， et al. Platelet membrane biomimetic nanoparticles combined with UTMD to improve the stability of atherosclerotic plaques ［J］. Front Chem， 2022， 2022： 191.
|
| 35 |
YIN M， LIN J， YANG M， et al. Platelet membrane-cloaked selenium/ginsenoside Rb1 nanosystem as biomimetic reactor for atherosclerosis therapy ［J］. Colloids Surf B Biointerfaces， 2022， 214： 112464.
|
| 36 |
ZHOU H， YOU P， LIU H， et al. Artemisinin and Procyanidins loaded multifunctional nanocomplexes alleviate atherosclerosis via simultaneously modulating lipid influx and cholesterol efflux ［J］. J Controll Rel， 2022， 341： 828-843.
|
| 37 |
PU H， YAO M， WU Z， et al. Regulation of the macrophage-related inflammatory microenvironment for atherosclerosis treatment and angiogenesis via anti-cytokine agents ［J］. Nano Res， 2022， 2022： 1-13.
|
| 38 |
SALAHEIDIN T A， GODUGU K， BHARALI D J， et al. Novel oral nano-hepatic targeted anti-PCSK9 in hypercholesterolemia ［J］. Nanomedicine， 2022， 40： 102480.
|
),王建茹2
